Skip to main content

Articles

Page 2 of 9

  1. This study aimed to investigate the relationship between low-dose prednisolone (PSL) and the incidence of hypokalaemia at abiraterone acetate (abiraterone) plus PSL combination therapy targeting Japanese patie...

    Authors: Shota Torii, Aya Torii-Goto, Tamaki Tanizawa, Takashi Sakakibara, Ryosuke Oguri, Haruka Nagase, Yuri Nakao, Tomoyuki Hirashita, Kuniaki Tanaka, Norio Takimoto and Takahiro Hayashi
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:72
    Content type: Research article Published on:

  2. Unlike in urban areas, community healthcare in medically underpopulated areas in Japan is constantly challenged because of the uncertainty in effectively using the limited resources. However, no study has focu...

    Authors: Yuji Nakagawa, Hideo Kato and Takuya Iwamoto
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:71
    Content type: Research article Published on:

  3. Famotidine, a histamine2-receptor antagonist (H2Ras), is widely used to treat and prevent gastrointestinal symptoms during pregnancy. Although several studies have reported the use of H2Ras during pregnancy, l...

    Authors: Ayako Nishimura, Ayako Furugen, Masaki Kobayashi, Yoh Takekuma, Naho Yakuwa, Mikako Goto, Masahiro Hayashi, Atsuko Murashima and Mitsuru Sugawara
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:70
    Content type: Research article Published on:

  4. Augmented renal clearance (ARC) decreases the therapeutic concentration of drugs excreted by the kidneys in critically ill patients. Several ARC prediction models have been developed and validated; however, th...

    Authors: Ryusei Mikami, Shungo Imai, Mineji Hayakawa, Hitoshi Kashiwagi, Yuki Sato, Shunsuke Nashimoto, Mitsuru Sugawara and Yoh Takekuma
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:69
    Content type: Research article Published on:

  5. Fluoroquinolone (FQ) antimicrobials have antipyretic effects during the treatment of bacterial infections; however, it is not clear whether these are due to their antimicrobial activities or their hypothermic ...

    Authors: Ryohei Hara, Kazuaki Taguchi, Hiromi Ogino, Yuko Okamoto, Yuki Enoki, Junko Kizu, Seiji Hori and Kazuaki Matsumoto
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:68
    Content type: Short report Published on:

  6. This study aimed to clarify the effectiveness of nutrition support team (NST) facilities for preventing central line-associated bloodstream infection (CLABSI).

    Authors: Akihiko Futamura, Takenao Koseki, Junichi Iida, Akito Suzuki, Nobuyuki Muroi, Michiaki Myotoku, Hiroki Maki, Kazuhisa Mizutani, Hikaru Ogino, Yasuki Taniguchi, Keiichiro Higashi and Masanobu Usui
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:67
    Content type: Research article Published on:

    The Correction to this article has been published in Journal of Pharmaceutical Health Care and Sciences 2025 11:1

  7. Edoxaban, the only factor Xa inhibitor with active metabolites, is metabolized by carboxylesterase-1 to its main active metabolite, M-4, which is a substrate of organic anion transporting polypeptide 1B1 (OATP...

    Authors: Junichi Nakagawa, Keinosuke Ishido, Norihisa Kimura, Hayato Nagase, Yusuke Wakasa, Satoshi Yokoyama, Kayo Ueno, Kenichi Hakamada and Takenori Niioka
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:66
    Content type: Case report Published on:

  8. The therapeutic landscape for ulcerative colitis (UC) has recently broadened to include anti-TNFα, anti-integrin, and anti-IL-12/23p40 antibody agents. These biological agents are tailored to individual patien...

    Authors: Arisa Fukuyama, Akio Nakashima, Motoyasu Miyazaki, Masakatsu Fujiki, Hideki Kakimoto, Takashi Hisabe and Osamu Imakyure
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:65
    Content type: Research article Published on:

  9. The support system for research activities has not been sufficiently established in clinical settings. A survey should be conducted to identify the causes of low research activity among pharmacists and the cha...

    Authors: Yuki Asai, Yasushi Takai, Hideo Kato, Shun-ichi Hiramatsu, Yoshihiro Miki, Naoki Masuda and Takuya Iwamoto
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:64
    Content type: Research article Published on:

  10. Morphine is effective in palliative care for patients with end-stage heart failure; however, its use is avoided in patients with impaired renal function because it tends to induce adverse effects. Although oxy...

    Authors: Masayuki Tanaka, Hirofumi Maeba, Takeshi Senoo, Nana Yoshimiya, Haruna Ozaki, Kazuki Uchitani, Noboru Tanigawa and Kazuichi Okazaki
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:63
    Content type: Research article Published on:

  11. Concerns persist regarding the potential reduction in driving performance due to taking second-generation antihistamines or performing hands-free calling. Previous studies have indicated a potential risk to dr...

    Authors: Atsunobu Sagara, Akihito Nagahama, Hayato Aki, Hiroki Yoshimura, Makoto Hiraide, Takatsune Shimizu, Motohiko Sano, Tetsuro Yumoto, Tomoo Hosoe and Kenji Tanaka
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:62
    Content type: Research article Published on:

  12. Understanding the roles and competencies of professions outside of one’s specialty is essential for providing efficient healthcare. However, it is difficult for medical professionals to understand the roles an...

    Authors: Fuka Aizawa, Hirofumi Hamano, Naoto Okada, Kenta Yagi, Mitsuhiro Goda, Hideki Nawa, Yuya Horinouchi, Toshimi Nakamura, Harumasa Hakuno, Kazuaki Shinomiya, Yoshito Zamami, Masahiko Azuma, Masashi Akaike and Keisuke Ishizawa
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:61
    Content type: Research article Published on:

  13. We examined whether denosumab-induced hypocalcaemia is evident in osteoporosis when given loop diuretics that promote urinary calcium excretion.

    Authors: Toshinori Hirai, Yukari Mori, Toru Ogura, Yuki Kondo, Yuka Sakazaki, Yoichi Ishitsuka, Akihiro Sudo and Takuya Iwamoto
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:60
    Content type: Research article Published on:

  14. Antimicrobial agents (AMAs) are essential for treating infections. A part of AMAs chelate with metal cations (MCs), reducing their blood concentrations. That drug-drug interaction could lead to a reduction of ...

    Authors: Takanori Matsumoto, Taichi Matsumoto, Chiyo Tsutsumi and Yoshiro Hadano
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:59
    Content type: Short report Published on:

  15. Multimodal analgesia (MMA) is recommended for postoperative pain management; however, studies evaluating the effect of tramadol-including MMA on numerical rating scale (NRS)-based postoperative pain levels and...

    Authors: Misa Okizuka, Ryo Inose, Satoshi Makio and Yuichi Muraki
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:58
    Content type: Research article Published on:

  16. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have been reported to have effects beyond lowering blood glucose levels, with certain SGLT2i expanding their indications to chronic kidney disease and chronic...

    Authors: Kazuya Hiura, Chinami Suzuki, Junichi Kubo, Haruka Goto, Shigo Takatori, Kiyomi Ishida, Yuki Tanaka, Akifumi Mizutani, Yuki Yamashita, Chiho Kurumazuka, Akihiko Takagi, Ryu Kobayashi and Akio Shibanami
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:57
    Content type: Research article Published on:

  17. Sacubitril/valsartan is an angiotensin receptor neprilysin inhibitor (ARNI) that inhibits the degradation of endogenous natriuretic peptides. Therefore, ARNIs may increase the efficacy of human atrial natriure...

    Authors: Tatsuki Yanagawa, Yuki Asai, Nobuyuki Zakoji, Shingo Hosoe, Yoshihiro Kondo, Shinnosuke Ootsuki, Hidekazu Kato, Maria Aoki, Yoshiaki Yamamoto, Takanori Yamamoto and Masaaki Takahashi
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:56
    Content type: Short report Published on:

  18. Brinzolamide (BRI) suspensions are used for the treatment of glaucoma; however, sufficient drug delivery to the target tissue after eye drop administration is hampered by poor solubility. To address this issue...

    Authors: Shuya Masuda, Shiho Yano, Tomohisa Tadokoro, Hiroko Otake and Noriaki Nagai
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:55
    Content type: Research article Published on:

  19. While nirmatrelvir/ritonavir (NMV-r) has been positioned as a first-line treatment for mild to moderate COVID-19, it has multiple and significant drug-drug interactions (DDIs). The use of NMV-r in Japan has be...

    Authors: Takeshi Tomida, Takeshi Kimura, Kazuhiro Yamamoto, Atsushi Uda, Yuki Matsumoto, Naoki Tamura, Masashi Iida, Akiko Tanifuji, Kumiko Matsumoto, Naomi Mizuta, Kei Ebisawa, Goh Ohji, Tomohiro Omura, Kentaro Iwata and Ikuko Yano
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:54
    Content type: Research article Published on:

  20. Fosphenytoin (FOS) is a prodrug of phenytoin (PHT) with a metabolism that exhibits Michaelis–Menten-type kinetics. Genetic polymorphisms of the metabolic enzymes of PHT make it challenging to predict its plasm...

    Authors: Ayumu Nagamine, Takuya Araki, Hideaki Yashima, Kiyohiro Oshima, Kyoko Obayashi and Koujirou Yamamoto
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:53
    Content type: Case report Published on:

  21. Interstitial lung disease (ILD) is one of the most common fatal immune-related adverse events (irAEs). ILD development adversely affects the continuation of anticancer drug therapy, including immune checkpoint...

    Authors: Mari Yokoi, Atsushi Yonezawa, Daiki Hira, Tomohiro Handa, Kiminobu Tanizawa, Shunsaku Nakagawa, Masahiro Tsuda, Yasuaki Ikemi, Ryo Itotani, Hironori Yoshida, Motoo Nomura, Junichi Matsubara, Kosaku Murakami, Hiroaki Ozasa, Manabu Muto and Tomohiro Terada
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:52
    Content type: Research article Published on:

  22. Pre-existing hypertension is reportedly a major risk factor for bevacizumab-induced proteinuria. However, few studies have focused on the effects of blood pressure (BP) control on proteinuria during bevacizuma...

    Authors: Satoru Nihei, Junichi Asaka, Mizunori Yaegashi, Koichi Asahi and Kenzo Kudo
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:51
    Content type: Research article Published on:

  23. Naldemedine is an orally available peripherally acting μ-opioid receptor antagonist approved to treat opioid-induced constipation (OIC). It is contraindicated for patients with known or suspected gastrointesti...

    Authors: Hayato Yokota, Yumiko Akamine, Mizuki Kobayashi, Takuro Kitabayashi, Misato Horie, Tentaro Endo, Takechiyo Yamada and Masafumi Kikuchi
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:50
    Content type: Case report Published on:

  24. Fasudil and ozagrel are drugs with the same indications for the treatment of cerebral vasospasm in Japan. However, there have been no definitive conclusions on the clinical efficacy of fasudil hydrochloride an...

    Authors: Hiroshi Magara, Takuaki Tani, Shinobu Imai, Anna Kiyomi, Kiyohide Fushimi and Munetoshi Sugiura
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:49
    Content type: Research article Published on:

  25. Drug-drug interactions (DDIs) increase the incidence of adverse drug reactions (ADRs). In a previous report, we revealed that the incidence of potential DDIs due to the same CYP molecular species in one prescr...

    Authors: Rina Matsuoka, Shinsuke Akagi, Tomohiro Konishi, Masashi Kondo, Hideki Matsubara, Shohei Yamamoto, Keiji Izushi and Yuichi Tasaka
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:48
    Content type: Research article Published on:

  26. Polypharmacy is an escalating public health concern across various healthcare settings worldwide. We aimed to comprehensively investigate postoperative complications after laparoscopic surgery for colorectal c...

    Authors: Takashi Watanabe, Shota Kashiwagura, Ryusuke Ouchi, Kensuke Usui, Chikashi Shibata and Kouji Okada
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:47
    Content type: Research article Published on:

  27. We examined whether the pharmacodynamic drug–drug interaction between esaxerenone and trimethoprim enhances the hyperkalemic effect.

    Authors: Toshinori Hirai, Shun Ueda, Toru Ogura, Kan Katayama, Kaoru Dohi, Yuki Kondo, Yuka Sakazaki, Yoichi Ishitsuka and Takuya Iwamoto
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:46
    Content type: Research article Published on:

  28. Pneumonia is a common infection in patients of all ages. Determining its etiology and selecting antibiotic therapy are challenging for physicians in both private practice and hospitals. Moreover, the coronavir...

    Authors: Hideo Kato
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:45
    Content type: Review Published on:

  29. Dispensed drugs stored by patients are often in single-dose packages (SDPs) or are crushed and mixed after being removed from a press-through package (PTP) sheet. Information on their stability is extremely li...

    Authors: Yuriko Murai, Kasumi Kudo, Hiroyuki Suzuki, Taisuke Konno, Yasuyuki Agatsuma and Hitoshi Nakamura
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:44
    Content type: Research article Published on:

  30. Nonhealing diabetic wounds are a serious complication associated with extremely lethargic wound closure and a high risk of infection, leading to amputation or limb loss, as well as substantial health care cost...

    Authors: Moustafa H. Moustafa, Mohamed S. Turkey, Noha S. Mohamedin, Amira A. Darwish, Amira A. M. Elshal, Mona A. H. Yehia, Mohamed M. El Safwany and Ehab I. Mohamed
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:43
    Content type: Research article Published on:

  31. Authors: Tamrat Assefa Tadesse, Amha Gebremedhin, Dejuma Yadeta, Legese Chelkeba and Teferi Gedif Fenta
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:42
    Content type: Publisher Correction Published on:

    The original article was published in Journal of Pharmaceutical Health Care and Sciences 2024 10:32

  32. Fentanyl is widely used as an analgesic and sedative for patients with severe burn injuries in intensive care units. However, pharmacokinetic (PK) data for fentanyl, particularly for continuous intravenous inf...

    Authors: Takafumi Nakano, Yasuhisa Oida, Shinichi Morimoto, Kentaro Muranishi, Soichiro Ushio, Takuya Yamashina, Masanobu Uchiyama, Kenichi Mishima, Kiyoyuki Kitaichi, Yoshihiko Nakamura and Koichi Matsuo
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:41
    Content type: Case report Published on:

  33. Gentamicin is a commonly used antibiotic with synergistic effects that is administered once or multiple times daily. However, the influence of the daily administration frequency on renal function has not yet b...

    Authors: Kyohei Sugiyama, Keita Hirai, Yukako Suyama and Masato Tsutsumi
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:40
    Content type: Research article Published on:

  34. Treating refractory status epilepticus (RSE) remains a challenge. Thiamylal can be used as a second- or third-line treatment; however, its potential to induce cytochrome P450 (CYP) activity may reduce the conc...

    Authors: Kazutaka Oda, Tomomi Katanoda, Hitomi Arakaki, Taiki Katsume, Kaho Matsuyama, Hirofumi Jono and Hideyuki Saito
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:39
    Content type: Case report Published on:

  35. Perioperative management of patients on dialysis is critical for controlling bleeding and thrombotic risk, in addition to infection control. Postoperative anticoagulation is often difficult to control, and dif...

    Authors: Masanori Suzuki, Yuki Hasegawa, Hiroaki Tanabe, Masayoshi Koinuma and Ryohkan Funakoshi
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:38
    Content type: Research article Published on:

  36. Among the oral antivirals used for treating patients with mild-to-moderate novel coronavirus disease 2019 (COVID-19), nirmatrelvir/ritonavir (NMV/RTV) and ensitrelvir (ESV) are inhibitors of cytochrome P450 (C...

    Authors: Hanako Naganawa, Yoshiki Katada, Shunsaku Nakagawa, Keisuke Umemura, Hiroki Ishimura, Moto Kajiwara, Hiroki Endo, Mitsuhiro Sugimoto, Yurie Katsube, Kinuka Kotani, Saki Ohta, Daiki Hira, Masahiro Tsuda, Yuki Kita, Takashi Kobayashi and Tomohiro Terada
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:37
    Content type: Case report Published on:

  37. Anamorelin is expected to improve cancer cachexia by increasing lean body mass (LBM) due to increased appetite and protein synthesis. However, the effect of anamorelin on cancer cachexia in real-world practice...

    Authors: Hironori Fujii, Akitaka Makiyama, Kayoko Nishimura, Hirotoshi Iihara, Chiemi Hirose, Koichi Ohata, Yunami Yamada, Daichi Watanabe, Itaru Yasufuku, Naoki Okumura, Yoshihiro Tanaka, Takao Takahashi, Ryo Kobayashi, Nobuhisa Matsuhashi and Akio Suzuki
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:36
    Content type: Research article Published on:

  38. We developed a reliable high-performance liquid chromatographic analysis method using a relative molar sensitivity (RMS) technique that does not require an authentic, identical reference analyte material to qu...

    Authors: Takashi Ohtsuki, Yi Huang, Ayane Kamiya, Yuki Nakayama, Miyuki Matsushita, Satoru Morikawa and Hiroshi Matsufuji
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:35
    Content type: Research article Published on:

  39. Guideline-directed medical therapy (GDMT) is important in heart failure management; however, polypharmacy itself may impact heart failure. Although measures against polypharmacy are needed, current discussion ...

    Authors: Daisuke Hayashi, Yoshiaki Kubota, Takuya Nishino, Yukihiro Watanabe, Yoshiki Iwade, Junya Matsuda, Katsuhito Kato, Shuhei Tara, Yuya Ise, Yu-ki Iwasaki and Kuniya Asai
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:34
    Content type: Research article Published on:

  40. Anamorelin, a drug to treat cancer cachexia, binds to ghrelin receptors and improves body weight and appetite. In clinical trials in Japan, patients experienced a 10.7% frequency of stimulant conduction system...

    Authors: Hayato Yokota, Ruriko Asahi, Yumiko Akamine, Mizuki Kobayashi, Hiyu Wakabayashi, Sho Sakamoto, Yuji Okuda, Kazuhiro Sato, Katsutoshi Nakayama and Masafumi Kikuchi
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:33
    Content type: Case report Published on:

  41. We aimed to compare anticoagulation control and outcomes between usual medical care (UMC) and pharmacist-led anticoagulation services (PLAS) in patients receiving warfarin at the Tikur Anbessa Specialized Hosp...

    Authors: Tamrat Assefa Tadesse, Amha Gebremedhin, Dejuma Yadeta, Legese Chelkeba and Teferi Gedif Fenta
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:32
    Content type: Research article Published on:

    The Publisher Correction to this article has been published in Journal of Pharmaceutical Health Care and Sciences 2024 10:42

  42. The improvement in flowability and adhesion of starch powder (SP) is essential for using starch as an excipient for lactose intolerant patients. In this study, we attempted to evaluate the usefulness of hydrox...

    Authors: Tomohiro Yoshikawa, Hiroyo Okamoto, Kenta Takeuchi, Atsushi Hirata, Hiroko Otake and Noriaki Nagai
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:31
    Content type: Short report Published on:

  43. Based on several case reports and observational studies, there is a growing concern regarding the potential association between roxadustat, a hypoxia-inducible factor prolyl-hydroxylase inhibitor, and suppress...

    Authors: Yuki Nakano, Satoru Mitsuboshi, Kazuhiro Tada and Kosuke Masutani
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:30
    Content type: Research article Published on:

  44. Patient satisfaction is a crucial humanistic outcome metric in pharmacy services. There was a lack of evidence on patients’ satisfaction with pharmacy services in Gamo zone among users and nonusers of the CBHI...

    Authors: Fitsum Teferi Gulta, Tidenek Mulugeta, Biruk Wogayehu and Mende Mensa
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:29
    Content type: Research article Published on:

  45. Ganciclovir and its prodrug, valganciclovir, are first-line agents for cytomegalovirus infection prophylaxis after lung transplantation. Although valganciclovir prophylaxis is known to result in severe leukope...

    Authors: Yoshiki Katada, Keisuke Umemura, Shunsaku Nakagawa, Yurie Katsube, Masahiro Tsuda, Satona Tanaka, Hiroshi Date, Miki Nagao and Tomohiro Terada
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:28
    Content type: Case report Published on:

  46. People living with human immunodeficiency virus (PLWH) require high rates of medication adherence to antiretroviral therapy (ART) for a successful treatment outcome. Understanding the factors associated with i...

    Authors: Yusuke Kunimoto, Shinichi Hikasa, Masashi Ishihara, Mariko Tsukiji, Kazuko Nobori, Takeshi Kimura, Kenta Onishi, Yuuki Yamamoto, Kyohei Haruta, Yohei Kasiwabara, Kenji Fujii and Masahide Fukudo
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:27
    Content type: Research article Published on:

  47. Ipilimumab (Ipi) plus nivolumab (Nivo) is the recommended first-line treatment for renal cell carcinoma (RCC). This report describes a case where pancreatic metastases disappeared after only two courses of Ipi...

    Authors: Ryo Takada, Miki Fujiwara, Masatoshi Maki, Naoyuki Nomura, Shintaro Kono, Akira Fujita, Hiroshi Masumoto, Yoko Takahashi, Yasuhisa Hasegawa and Koji Tamura
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:26
    Content type: Case report Published on:

  48. COMISA is a common disorder that results in nighttime awakenings ,daytime sleepiness and PAP intolerance. Cognitive behavioral therapy for insomnia is used to improve PAP adherence and no medication has been e...

    Authors: Tahereh Madani Motlaq, Besharat Rahimi and Shahideh Amini
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:25
    Content type: Research article Published on:

  49. Pimobendan reportedly improves the subjective symptoms of heart failure. However, evidence of improved prognosis is lacking. This study aimed to determine whether reinforcing guideline-directed medical therapy...

    Authors: Yoshiki Iwade, Yoshiaki Kubota, Daisuke Hayashi, Takuya Nishino, Yukihiro Watanabe, Katsuhito Kato, Shuhei Tara, Yuya Ise and Kuniya Asai
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:24
    Content type: Short report Published on:

  50. Coronary heart disease, also known as ischemic heart disease, is induced by atherosclerosis, which is initiated by subendothelial retention of lipoproteins. Plasma lipoproteins, including high density lipoprot...

    Authors: Shin-ya Morita
    Citation: Journal of Pharmaceutical Health Care and Sciences 2024 10:23
    Content type: Review Published on:
JSPHCS

Official journal of JSPHCS

Submit manuscript

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 1.2
    5-year Journal Impact Factor: 1.4
    Source Normalized Impact per Paper (SNIP): 0.557
    SCImago Journal Rank (SJR): 0.312

    Speed 2024
    Submission to first editorial decision (median days): 7
    Submission to acceptance (median days): 79

    Usage 2024
    Downloads: 301,150
    Altmetric mentions: 116

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us